Journal for ImmunoTherapy of Cancer (Nov 2023)

770 ADU-1604, a novel CTLA-4 blocking antibody modulates pharmacodynamic markers in PD1 relapse/refractory melanoma patients

  • Caroline Robert,
  • Ivan Marquez-Rodas,
  • Michele Maio,
  • Vanna Chiarion-Sileni,
  • Piotr Rutkowski,
  • Hans Van Eenennaam,
  • Julien Villaudy,
  • Jessica Kundapur,
  • Ana Maria Arance,
  • Alexander Eggermont,
  • Guillemo De Velasco Oria de Rueda,
  • Laura Lassouw-Polman

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0770
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.